These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29038312)

  • 1. Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth.
    Mathivet T; Bouleti C; Van Woensel M; Stanchi F; Verschuere T; Phng LK; Dejaegher J; Balcer M; Matsumoto K; Georgieva PB; Belmans J; Sciot R; Stockmann C; Mazzone M; De Vleeschouwer S; Gerhardt H
    EMBO Mol Med; 2017 Dec; 9(12):1629-1645. PubMed ID: 29038312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.
    Baker GJ; Yadav VN; Motsch S; Koschmann C; Calinescu AA; Mineharu Y; Camelo-Piragua SI; Orringer D; Bannykh S; Nichols WS; deCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Neoplasia; 2014 Jul; 16(7):543-61. PubMed ID: 25117977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of anti-VEGF therapy and temozolomide in two experimental human glioma models.
    Grossman R; Brastianos H; Blakeley JO; Mangraviti A; Lal B; Zadnik P; Hwang L; Wicks RT; Goodwin RC; Brem H; Tyler B
    J Neurooncol; 2014 Jan; 116(1):59-65. PubMed ID: 24185441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors.
    Brandenburg S; Müller A; Turkowski K; Radev YT; Rot S; Schmidt C; Bungert AD; Acker G; Schorr A; Hippe A; Miller K; Heppner FL; Homey B; Vajkoczy P
    Acta Neuropathol; 2016 Mar; 131(3):365-78. PubMed ID: 26718201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    Cancer Biol Ther; 2014 Apr; 15(4):398-408. PubMed ID: 24424202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.
    Osterberg N; Ferrara N; Vacher J; Gaedicke S; Niedermann G; Weyerbrock A; Doostkam S; Schaefer HE; Plate KH; Machein MR
    Neuro Oncol; 2016 Jul; 18(7):939-49. PubMed ID: 26951383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
    Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
    J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy.
    Zhu X; Fujita M; Snyder LA; Okada H
    J Neurooncol; 2011 Aug; 104(1):83-92. PubMed ID: 21116835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma.
    Narayana A; Golfinos JG; Fischer I; Raza S; Kelly P; Parker E; Knopp EA; Medabalmi P; Zagzag D; Eagan P; Gruber ML
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):383-9. PubMed ID: 18793954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
    Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
    J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
    Doucette TA; Kong LY; Yang Y; Ferguson SD; Yang J; Wei J; Qiao W; Fuller GN; Bhat KP; Aldape K; Priebe W; Bögler O; Heimberger AB; Rao G
    Neuro Oncol; 2012 Sep; 14(9):1136-45. PubMed ID: 22753228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling.
    Lan T; Zhao Z; Qu Y; Zhang M; Wang H; Zhang Z; Zhou W; Fan X; Yu C; Zhan Q; Song Y
    Oncotarget; 2016 Aug; 7(34):55555-55571. PubMed ID: 27487130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
    Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
    Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response.
    Smith SJ; Ward JH; Tan C; Grundy RG; Rahman R
    Oncotarget; 2015 Sep; 6(26):22191-205. PubMed ID: 26203665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma.
    Qin T; Wang C; Chen X; Duan C; Zhang X; Zhang J; Chai H; Tang T; Chen H; Yue J; Li Y; Yang J
    Toxicol Appl Pharmacol; 2015 Jul; 286(2):112-23. PubMed ID: 25818600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
    McConville P; Hambardzumyan D; Moody JB; Leopold WR; Kreger AR; Woolliscroft MJ; Rehemtulla A; Ross BD; Holland EC
    Clin Cancer Res; 2007 May; 13(10):2897-904. PubMed ID: 17504989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma.
    Magaña-Maldonado R; Manoutcharian K; Hernández-Pedro NY; Rangel-López E; Pérez-De la Cruz V; Rodríguez-Balderas C; Sotelo J; Pineda B
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):291-301. PubMed ID: 24337403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting enhances the response of glioma to chemo- and radiotherapy.
    Safdie F; Brandhorst S; Wei M; Wang W; Lee C; Hwang S; Conti PS; Chen TC; Longo VD
    PLoS One; 2012; 7(9):e44603. PubMed ID: 22984531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promises and controversies in the management of low-grade glioma.
    Stupp R; Baumert BG
    Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization.
    Claes A; Wesseling P; Jeuken J; Maass C; Heerschap A; Leenders WP
    Mol Cancer Ther; 2008 Jan; 7(1):71-8. PubMed ID: 18187807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.